Pages that link to "Q37728357"
Jump to navigation
Jump to search
The following pages link to Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury (Q37728357):
Displaying 12 items.
- Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists (Q34645842) (← links)
- Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition. (Q35071380) (← links)
- Novel 3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]propanamides as selective agonists of human formyl-peptide receptor 2 (Q35738729) (← links)
- 3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2 (Q36557131) (← links)
- Adh enhances Actinobacillus pleuropneumoniae pathogenicity by binding to OR5M11 and activating p38 which induces apoptosis of PAMs and IL-8 release (Q36764910) (← links)
- The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition (Q39196591) (← links)
- The Adh adhesin domain is required for trimeric autotransporter Apa1-mediated Actinobacillus pleuropneumoniae adhesion, autoaggregation, biofilm formation and pathogenicity. (Q41146648) (← links)
- Functional N-Formyl Peptide Receptor 2 (FPR2) Antagonists Based on the Ureidopropanamide Scaffold Have Potential To Protect Against Inflammation-Associated Oxidative Stress (Q46305001) (← links)
- Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation (Q47441885) (← links)
- Ligand-free Cu(ii)-mediated aerobic oxidations of aldehyde hydrazones leading to N,N'-diacylhydrazines and 1,3,4-oxadiazoles. (Q48156333) (← links)
- Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors (Q92128444) (← links)
- Anti-inflammatory signaling through G protein-coupled receptors (Q100635354) (← links)